このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Mangalam Drugs & Organics マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Govardhan Dhoot
最高経営責任者
₹2.0m
報酬総額
| CEO給与比率 | 100.0% |
| CEO在任期間 | 28.3yrs |
| CEOの所有権 | 6.8% |
| 経営陣の平均在職期間 | データなし |
| 取締役会の平均在任期間 | 6.5yrs |
経営陣の近況
Recent updates
Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues Are Not Doing Enough For Some Investors
Aug 13
A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
May 23Little Excitement Around Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues As Shares Take 25% Pounding
Mar 28Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Shares Lagging The Industry But So Is The Business
Feb 07Estimating The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Oct 20Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Mar 29These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively
May 31A Look At The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Apr 06We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt
Jan 03Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly
May 23Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Jan 04Do Its Financials Have Any Role To Play In Driving Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Stock Up Recently?
Nov 12
A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Sep 20Does Mangalam Drugs & Organics's (NSE:MANGALAM) Statutory Profit Adequately Reflect Its Underlying Profit?
Aug 05We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt
Jul 01CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -₹91m |
| Dec 31 2023 | n/a | n/a | -₹170m |
| Sep 30 2023 | n/a | n/a | -₹171m |
| Jun 30 2023 | n/a | n/a | -₹113m |
| Mar 31 2023 | ₹2m | ₹2m | ₹13m |
| Dec 31 2022 | n/a | n/a | ₹123m |
| Sep 30 2022 | n/a | n/a | ₹159m |
| Jun 30 2022 | n/a | n/a | ₹182m |
| Mar 31 2022 | ₹2m | ₹2m | ₹197m |
| Dec 31 2021 | n/a | n/a | ₹151m |
| Sep 30 2021 | n/a | n/a | ₹175m |
| Jun 30 2021 | n/a | n/a | ₹241m |
| Mar 31 2021 | ₹2m | n/a | ₹280m |
| Dec 31 2020 | n/a | n/a | ₹309m |
| Sep 30 2020 | n/a | n/a | ₹261m |
| Jun 30 2020 | n/a | n/a | ₹158m |
| Mar 31 2020 | ₹5m | ₹2m | ₹83m |
| Dec 31 2019 | n/a | n/a | -₹28m |
| Sep 30 2019 | n/a | n/a | -₹89m |
| Jun 30 2019 | n/a | n/a | -₹80m |
| Mar 31 2019 | ₹2m | ₹2m | -₹80m |
| Dec 31 2018 | n/a | n/a | ₹10m |
| Sep 30 2018 | n/a | n/a | ₹114m |
| Jun 30 2018 | n/a | n/a | ₹164m |
| Mar 31 2018 | ₹2m | ₹2m | ₹199m |
報酬と市場: Govardhanの 総報酬 ($USD 23.97K ) は、 Indian市場 ($USD 38.53K ) の同様の規模の企業の平均を下回っています。
報酬と収益: Govardhanの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Govardhan Dhoot (71 yo)
28.3yrs
在職期間
₹2,000,000
報酬
Mr. Govardhan Murlidhar Dhoot serves as the Chairman of the Board and Managing Director at Mangalam Drugs & Organics Limited and has been its Executive Director since April 16, 1996.
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman & MD | 28.3yrs | ₹2.00m | 6.81% ₹ 134.6m | |
| Whole-Time Director | 9.3yrs | ₹600.00k | 3.57% ₹ 70.6m | |
| Independent Director | 6.8yrs | ₹36.00k | データなし | |
| Non-Executive Independent Director | 6.3yrs | ₹42.00k | データなし | |
| Independent Non-Executive Director | 3.4yrs | ₹24.00k | データなし | |
| Non-Executive Non- Independent Director | 2.4yrs | ₹16.00k | データなし |
6.5yrs
平均在職期間
69yo
平均年齢
経験豊富なボード: MANGALAMの 取締役会 は 経験豊富 であると考えられます ( 6.3年の平均在任期間)。